Using propofol − what is forbidden, is not (really) allowed ... or what are we risking if we use it in contradiction with the SPC?
Authors:
R. Černá Pařízková
Authors‘ workplace:
Klinika anesteziologie, resuscitace a intenzivní medicíny, Lékařská fakulta v Hradci Králové, Univerzita Karlova
Published in:
Anest. intenziv. Med., 29, 2018, č. 5, s. 293-296
Category:
Overview
Propofol is an intravenous anaesthetic agent based on lipid emulsion without antimicrobial additive with high risk of microbial growth. Non-compliance with the recommended SPC (Summary of Product Characteristics) administration was associated with serious infectious complications. The aim of the article is to analyze the ethical and legal problems that can be associated with incorrect practice of using propofol.
KEYWORDS:
propofol – contamination – good clinical practice
Labels
Anaesthesiology, Resuscitation and Inten Intensive Care MedicineArticle was published in
Anaesthesiology and Intensive Care Medicine
2018 Issue 5
- Invasive Pulmonary Aspergillosis – A Common Accompanying Infection in Patients with Severe or Critical Course of COVID-19
- Intestinal Infection of Multi-Resistant NDM-Producing K. pneumoniae in a Patient with NK/T Lymphoma – Case Study
- Vitamins in Prevention and Treatment of COVID-19
- Hybrid Cooperating Complexes in Osteoarthritis Treatment
Most read in this issue
- Using propofol − what is forbidden, is not (really) allowed ... or what are we risking if we use it in contradiction with the SPC?
- Regional anaesthesia for knee joint surgery – peripheral nerve blocks with minimal impact on motor function of the lower limb
- Effects of infusion solution on blood coagulation
- Cytomegalovirus infection in intensive care. Treat or ignore them?